CIK 0001446847 · Accelerated filer<br>Smaller reporting company
IRONWOOD PHARMACEUTICALS INC
Sign in to watch- Ticker
- IRWD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043404176
- Phone
- 617-621-7722
- Business address
- 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-08 | Shetzline Michael CMO,SVP,Head-Res&Drug | Option exercise · Performance-based Restricted Stock Unit | −34,936 | 0 | ||
| 2024-03-06 | Duane Jon R Director | Purchase | +6,920 | $8.70 | $60K | 121,028 |
| 2024-03-05 | MCCOURT Thomas A Chief Executive Officer | Grant or award | +264,876 | 1,097,650 | ||
| 2024-03-05 | MCCOURT Thomas A Chief Executive Officer | Grant or award · Performance-based Restricted Stock Unit | +132,438 | 132,438 | ||
| 2024-03-04 | Emany Sravan Kumar SVP, Chief Financial Officer | Purchase | +10,684 | $9.38 | $100K | 301,733 |
| 2024-02-12 | John Minardo Chief Legal Officer | Sale | −47,380 | $15.24 | $722K | 224,796 |
| 2024-02-12 | John Minardo Chief Legal Officer | Grant or award | +54,427 | 279,223 | ||
| 2024-02-12 | John Minardo Chief Legal Officer | Grant or award · Performance-based Restricted Stock Unit | +27,214 | 27,214 | ||
| 2024-02-12 | Shetzline Michael CMO,SVP,Head-Res&Drug | Sale | −38,618 | $15.24 | $589K | 340,484 |
| 2024-02-12 | Shetzline Michael CMO,SVP,Head-Res&Drug | Grant or award | +54,427 | 394,911 | ||
| 2024-02-12 | Shetzline Michael CMO,SVP,Head-Res&Drug | Grant or award · Performance-based Restricted Stock Unit | +27,214 | 27,214 | ||
| 2024-02-12 | Silver Ronald Principal Accounting Officer | Sale | −7,908 | $15.24 | $121K | 134,264 |
| 2024-02-12 | Silver Ronald Principal Accounting Officer | Grant or award | +27,213 | 161,477 | ||
| 2024-02-12 | Davis Andrew SVP, Chief Business Officer | Sale | −9,846 | $15.24 | $150K | 208,324 |
| 2024-02-12 | Davis Andrew SVP, Chief Business Officer | Grant or award | +65,312 | 273,636 | ||
| 2024-02-12 | Davis Andrew SVP, Chief Business Officer | Grant or award · Performance-based Restricted Stock Unit | +32,656 | 32,656 | ||
| 2024-02-12 | Emany Sravan Kumar SVP, Chief Financial Officer | Grant or award | +65,312 | 291,049 | ||
| 2024-02-12 | Emany Sravan Kumar SVP, Chief Financial Officer | Grant or award · Performance-based Restricted Stock Unit | +32,656 | 32,656 | ||
| 2024-02-12 | MCCOURT Thomas A Chief Executive Officer | Sale | −177,164 | $15.24 | $2.7M | 832,774 |
| 2024-02-08 | Emany Sravan Kumar SVP, Chief Financial Officer | Shares withheld for taxes | −41,332 | $14.90 | $616K | 225,737 |
Page 6 of 7 · 128 trades